Why the study?
Does the addition of levamisole, methisoprinol, adenine, or adenosine potentiate the antiviral activity of human interferon against encephalomyocarditis virus in HeLa cells?
Does the addition of levamisole, methisoprinol, adenine, or adenosine potentiate the antiviral activity of human interferon against encephalomyocarditis virus in HeLa cells?
Levamisole, methisoprinol, adenine, and adenosine significantly potentiate the antiviral activity of human interferon against encephalomyocarditis virus in vitro.
Answers are grounded in this paper and cite their sources.
Cell data should not guide interferon use; leaves open need for in vivo trials of these adjuvants.
The antiviral action of different human interferons against encephalomyocarditis virus in HeLa cell cultures was analyzed. Cell treatment with levamisole (200 micrograms/ml), methisoprinol (1 mg/ml), or adenine or adenosine (33 or 100 micrograms/ml, respectively) potentiated the anti-encephalomyocarditis virus activity of human interferon by 8- to 32-fold. A higher level of potentiation (256-fold) was achieved either by combined treatments with levamisole plus methisoprinol or by treatment with one of these compounds plus adenine or adenosine.
No takes yet. Share an insight, caveat, or question.
Múñoz et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: